Ralf Heilker

2.7k total citations · 1 hit paper
47 papers, 2.1k citations indexed

About

Ralf Heilker is a scholar working on Molecular Biology, Biophysics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ralf Heilker has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 13 papers in Biophysics and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ralf Heilker's work include Advanced Fluorescence Microscopy Techniques (9 papers), Receptor Mechanisms and Signaling (8 papers) and Advanced Biosensing Techniques and Applications (7 papers). Ralf Heilker is often cited by papers focused on Advanced Fluorescence Microscopy Techniques (9 papers), Receptor Mechanisms and Signaling (8 papers) and Advanced Biosensing Techniques and Applications (7 papers). Ralf Heilker collaborates with scholars based in Germany, United States and United Kingdom. Ralf Heilker's co-authors include Hideaki Tada, Toru Nakano, Tasuku Honjo, Kei Tashiro, Michael W. Wolff, Martin Spiess, G. Ulrich Nienhaus, Jörg Wiedenmann, Martin J. Valler and Karin Nienhaus and has published in prestigious journals such as Science, Journal of the American Chemical Society and The EMBO Journal.

In The Last Decade

Ralf Heilker

46 papers receiving 2.1k citations

Hit Papers

Signal Sequence Trap: a Cloning Strategy for Secreted Pro... 1993 2026 2004 2015 1993 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralf Heilker Germany 23 1.2k 525 464 361 318 47 2.1k
Karl‐Johan Leuchowius Sweden 11 2.3k 1.9× 363 0.7× 394 0.8× 117 0.3× 293 0.9× 15 3.2k
Amy N. Abell United States 24 1.7k 1.4× 448 0.9× 379 0.8× 112 0.3× 225 0.7× 34 3.0k
Jérémie Rossy Australia 24 897 0.8× 600 1.1× 235 0.5× 519 1.4× 84 0.3× 40 2.0k
Malin Jarvius Sweden 20 2.6k 2.2× 392 0.7× 606 1.3× 122 0.3× 338 1.1× 38 3.7k
Andreas Girod Germany 18 1.6k 1.4× 547 1.0× 163 0.4× 327 0.9× 173 0.5× 23 2.6k
Etsuko Kiyokawa Japan 31 2.3k 2.0× 550 1.0× 287 0.6× 192 0.5× 304 1.0× 71 3.4k
Kiyoko Fukami Japan 12 2.2k 1.9× 248 0.5× 380 0.8× 325 0.9× 272 0.9× 14 3.3k
Zachary C. Dobbin United States 15 1.3k 1.1× 175 0.3× 475 1.0× 127 0.4× 160 0.5× 18 2.2k
Brian A. Pollok United States 22 2.6k 2.2× 818 1.6× 617 1.3× 210 0.6× 322 1.0× 41 4.0k
Marie K. Schwinn United States 15 2.1k 1.8× 182 0.3× 320 0.7× 102 0.3× 235 0.7× 22 2.7k

Countries citing papers authored by Ralf Heilker

Since Specialization
Citations

This map shows the geographic impact of Ralf Heilker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Heilker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Heilker more than expected).

Fields of papers citing papers by Ralf Heilker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Heilker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Heilker. The network helps show where Ralf Heilker may publish in the future.

Co-authorship network of co-authors of Ralf Heilker

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Heilker. A scholar is included among the top collaborators of Ralf Heilker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Heilker. Ralf Heilker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
King, Jim, et al.. (2024). Recapitulation of NOD/RIPK2 signaling in iPSC-derived macrophages. SLAS DISCOVERY. 29(7). 100185–100185.
2.
Kasmi, Karim C. El, et al.. (2023). Application of human iPSC-derived macrophages in a miniaturized high-content-imaging-based efferocytosis assay. SLAS DISCOVERY. 28(4). 149–162. 4 indexed citations
3.
Schruf, Eva, et al.. (2019). Differentiation of hiPS Cells into Definitive Endoderm for High-Throughput Screening. Methods in molecular biology. 1994. 101–115. 1 indexed citations
4.
Stahl, Heiko, et al.. (2016). Upscaling of hiPS Cell–Derived Neurons for High-Throughput Screening. SLAS DISCOVERY. 22(3). 274–286. 9 indexed citations
5.
Wolff, Michael W., et al.. (2014). Phenotypic Analysis of Chemokine-Driven Actin Reorganization in Primary Human Neutrophils. Assay and Drug Development Technologies. 12(2). 120–128. 4 indexed citations
6.
Wolff, Michael W., Kay Tetzlaff, Michael C. Nivens, et al.. (2010). In vivo inhibition of epidermal growth factor receptor autophosphorylation prevents receptor internalization. Experimental Cell Research. 317(1). 42–50. 2 indexed citations
7.
East, Stephen P., Christian Eickmeier, Adam Flegg, et al.. (2010). An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction. Bioorganic & Medicinal Chemistry Letters. 20(16). 4901–4905. 36 indexed citations
8.
Wolff, Michael W., Jörg Wiedenmann, Barbara Moepps, et al.. (2009). CXCR2 Inverse Agonism Detected by Arrestin Redistribution. SLAS DISCOVERY. 14(9). 1076–1091. 3 indexed citations
9.
Woodruff, Prescott G., Michael W. Wolff, Jens M. Hohlfeld, et al.. (2009). Safety and Efficacy of an Inhaled Epidermal Growth Factor Receptor Inhibitor (BIBW 2948 BS) in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 181(5). 438–445. 63 indexed citations
10.
Oswald, Franz, Karin Nienhaus, Karen Deuschle, et al.. (2009). mRuby, a Bright Monomeric Red Fluorescent Protein for Labeling of Subcellular Structures. PLoS ONE. 4(2). e4391–e4391. 173 indexed citations
11.
Heilker, Ralf, et al.. (2009). G-protein-coupled receptor-focused drug discovery using a target class platform approach. Drug Discovery Today. 14(5-6). 231–240. 117 indexed citations
12.
Nienhaus, Karin, Franz Oswald, Michael W. Wolff, et al.. (2008). Optimized and Far-Red-Emitting Variants of Fluorescent Protein eqFP611. Chemistry & Biology. 15(3). 224–233. 60 indexed citations
13.
Wolff, Michael W., et al.. (2008). Cell-Based Assays in Practice: Cell Markers from Autofluorescent Proteins of the GFP-Family. Combinatorial Chemistry & High Throughput Screening. 11(8). 602–609. 7 indexed citations
14.
Wolff, Michael W., Joerg Wiedenmann, G. Ulrich Nienhaus, Martin J. Valler, & Ralf Heilker. (2006). Novel fluorescent proteins for high-content screening. Drug Discovery Today. 11(23-24). 1054–1060. 34 indexed citations
15.
Haasen, Dorothea, Michael W. Wolff, Martin J. Valler, & Ralf Heilker. (2005). Comparison of G-Protein Coupled Receptor Desensitization-Related β- Arrestin Redistribution Using Confocal and Non-Confocal Imaging. Combinatorial Chemistry & High Throughput Screening. 9(1). 37–47. 17 indexed citations
16.
Nienhaus, G. Ulrich, Karin Nienhaus, Sergey Ivanchenko, et al.. (2005). Photoconvertible Fluorescent Protein EosFP: Biophysical Properties and Cell Biology Applications. Photochemistry and Photobiology. 82(2). 351–358. 104 indexed citations
17.
Schenk, Andreas D., et al.. (2003). Confocal optics microscopy for biochemical and cellular high-throughput screening. Drug Discovery Today. 8(23). 1085–1093. 73 indexed citations
19.
Heilker, Ralf, Martin Spiess, & Pascal Crottet. (1999). Recognition of sorting signals by clathrin adaptors. BioEssays. 21(7). 558–567. 118 indexed citations
20.
Heilker, Ralf, et al.. (1999). All three IκB isoforms and most Rel family members are stably associated with the IκB kinase 1/2 complex. European Journal of Biochemistry. 259(1-2). 253–261. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026